From the President: PSA at the FIP World Congress in Seville,...

I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...

From the President: For 25 years, accreditation has paved the way

For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.

Prenatal vitamin D for schizophrenia

The genetic and environmental factors behind schizophrenia are poorly understood, but research is increasingly finding links between maternal vitamin D status and the risk...

New COVID-19 case in Byron Bay means limited restrictions are back

Queensland recorded three new cases of COVID-19 today (31 March), as residents of Greater Brisbane wait to hear if they will spend the Easter break in lockdown.

The pain of uncertainty: Managing pain without codeine

With over-the-counter (OTC) codeine products being upscheduled, pharmacists and pharmacy staff need to review and understand every patient’s pain. In doing so, there’s an...

Government commits $25m to medicine safety research

The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.